MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit
By Dean Seal MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesnt meet regulatory requirements for a certain classification sought by the...
Source: marketscreener.com